Drug · DIN 02464241
VEMLIDY
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 20, 2017; first marketed June 20, 2017.
- Drug Identification Number (DIN)
- 02464241
- Company (DIN owner)
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Tenofovir alafenamide J05AF13
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TENOFOVIR ALAFENAMIDE (TENOFOVIR ALAFENAMIDE HEMIFUMARATE) | 25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 17, 2017: NOC 19317New Drug Submission (NDS)